Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aya Nakamura

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Infectious Diseases and Therapy|February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial DecisionsStephen J Balevic, Shruti M Raja, Rachel Randell, et al.
The Journal of Biological Chemistry|January 16, 2004
A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAcToru Hiruma, Akira Togayachi, Kayo Okamura, et al.
Eneurologicalsci|December 21, 2017
Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during strokeMadoka Yoshida, Naoki Kato, Takeshi Uemura, et al.
Journal of Neuro-Oncology|September 20, 2019
Long term results of primary radiosurgery for vestibular schwannomasStephen Johnson, Hideyuki Kano, Andrew Faramand, et al.
Vaccine|December 28, 2017
Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Hana M El Sahly, Sarah George, et al.
Vaccine|February 12, 2018
Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination seriesLea E Widdice, Rebecca Hoagland, S Todd Callahan, et al.
Human Vaccines & Immunotherapeutics|August 5, 2020
Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adultsFelicia Scaggs Huang, David I Bernstein, Karen S Slobod, et al.
The Journal of Infectious Diseases|January 28, 2021
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome CoronavirusSumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, et al.
Vaccines|July 8, 2020
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 ExposureLilin Lai, Kevin Ault, Nadine Rouphael, et al.
Cell Stem Cell|December 8, 2023
Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosaYasuhiko Hirami, Michiko Mandai, Sunao Sugita, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Infectious Diseases and Therapy|February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial DecisionsStephen J Balevic, Shruti M Raja, Rachel Randell, et al.
The Journal of Biological Chemistry|January 16, 2004
A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAcToru Hiruma, Akira Togayachi, Kayo Okamura, et al.
Eneurologicalsci|December 21, 2017
Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during strokeMadoka Yoshida, Naoki Kato, Takeshi Uemura, et al.
Journal of Neuro-Oncology|September 20, 2019
Long term results of primary radiosurgery for vestibular schwannomasStephen Johnson, Hideyuki Kano, Andrew Faramand, et al.
Vaccine|December 28, 2017
Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccineLisa A Jackson, Hana M El Sahly, Sarah George, et al.
Vaccine|February 12, 2018
Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination seriesLea E Widdice, Rebecca Hoagland, S Todd Callahan, et al.
Human Vaccines & Immunotherapeutics|August 5, 2020
Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adultsFelicia Scaggs Huang, David I Bernstein, Karen S Slobod, et al.
The Journal of Infectious Diseases|January 28, 2021
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome CoronavirusSumathi Sivapalasingam, George A Saviolakis, Kirsten Kulcsar, et al.
Vaccines|July 8, 2020
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 ExposureLilin Lai, Kevin Ault, Nadine Rouphael, et al.
Cell Stem Cell|December 8, 2023
Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosaYasuhiko Hirami, Michiko Mandai, Sunao Sugita, et al.
Pageof 5